The HHS National Alzheimer's Plan Update for 2026-2035 gives spouses and partners three 2026 jobs: get support, seek timely diagnosis, and lower risk. The National Plan to Address Alzheimer's Disease and Related Dementias is the federal strategy for prevention, care, and family support through 2035.
HHS released the 2026 Update on Oct. 22, 2026, replacing six older goals with four lifespan priorities: risk reduction, discovery and innovation, high-value care, and family supports, according to HHS in the national plan document. Congress extended the federal project through 2035 in 2024, so these priorities set the current action frame.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What changed in the federal plan?
- Can you get GUIDE support and respite?
- Should you ask about evaluation sooner?
- What lowers risk for both of you?
What changed in the federal plan?
The four priorities move spouses closer to the center. Risk reduction covers both partners.
High-value care and family supports cover daily care needs. Discovery and innovation aim to speed better tests and treatments. Psychiatric Times reports that FDA launched an Alzheimer's Prevention Accelerator and ARPA-H announced up to $48.8 million for earlier-detection and early-intervention projects tied to the update.
Can you get GUIDE support and respite?
Medicare's GUIDE Model is an eight-year program from July 1, 2024 to June 30, 2032, according to CMS. It pairs dementia care coordination with education, support, and respite for qualifying unpaid caregivers, often spouses and partners.
Check these points with a participating provider: CMS caps GUIDE respite at $2,625 per patient for July 2026 through June 2027 for in-home, adult-day, or facility-based relief, according to CMS in the GUIDE respite fact sheet. From July 1, 2026, patients in residential care or memory-care units can receive most GUIDE services but not GUIDE respite, according to CMS.
- Patient has Traditional Medicare and a dementia diagnosis
- Spouse or partner serves as unpaid caregiver
- Care is arranged through a GUIDE participant
Should you ask about evaluation sooner?
Yes, if you see ongoing change in memory, thinking, or daily tasks. A partner's notes about timing, examples, and safety issues help a clinician judge next steps.
FDA cleared the first blood test to aid Alzheimer's diagnosis on May 16, 2025 for symptomatic adults age 55 and older in specialty care, according to the Alzheimer's Association in its FDA clearance report. The test is the Fujirebio Lumipulse G pTau217 and beta-amyloid 1-42 ratio. Ask specialty care whether earlier, less invasive evaluation fits your situation.
What lowers risk for both of you?
CDC advises staying physically active, controlling high blood pressure, and treating hearing loss, according to CDC in its prevention guidance. Lack of activity, hypertension, and hearing loss each raise dementia risk. Make it shared and specific.
Walk together most days. Keep blood pressure follow-up on the calendar. Treat hearing trouble promptly instead of turning up the volume. Book a hearing check this month if conversations have gotten harder to follow.
You Might Also Like
- The HHS National Alzheimer’s Plan Update for 2026-2035: What Comes Next and What Spouses and Partners Should Watch
- CMS GUIDE Dementia Quality Measures for 2026: A 2026 Action Checklist for Medicare Families
- Building Reducing Alcohol Use Into a Realistic Dementia Prevention Routine in a 2026 Brain Health Plan
